Benitec Biopharma (BNTC) Operating Leases (2019 - 2025)
Benitec Biopharma's (BNTC) quarterly Operating Leases came in at $987000.0 in Q4 2025, up 620.44% year-on-year from $137000.0 in Q4 2024, and up 20.81% quarter-over-quarter from $817000.0 in Q3 2025.
Benitec Biopharma (BNTC) Operating Leases (2019 - 2025) Analysis & Trends
Benitec Biopharma has disclosed Operating Leases across 7 years of filings, most recently posting $987000.0 for Q4 2025.
- Operating Leases for Q4 2025 came in at $987000.0, up 620.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $987000.0 (up 620.44% YoY), and the FY2025 annual result was $495000.0, up 74.3% from the prior year.
- Operating Leases came in at $987000.0 for Q4 2025 at Benitec Biopharma, up from $817000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $987000.0 in Q4 2025 to a low of $62000.0 in Q1 2024.
- The 5-year median for Operating Leases is $422500.0 (2022), against an average of $478650.0.
- Across the five-year window, Operating Leases plunged 82.49% in 2024 and jumped 888.71% in 2025, its largest moves.
- Benitec Biopharma's Operating Leases stood at $698000.0 in 2021, then fell by 1.86% to $685000.0 in 2022, then tumbled by 80.0% to $137000.0 in 2023, then changed by 0.0% to $137000.0 in 2024, then soared by 620.44% to $987000.0 in 2025.
- The last three Operating Leases figures came in at $987000.0 (Q4 2025), $817000.0 (Q3 2025), and $495000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Benitec Biopharma | 488.21 Mn | 488.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 987,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 284,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 137,000.00 |
| Sep 30, 2023 | 211,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | 354,000.00 |
| Dec 31, 2022 | 685,000.00 |
| Sep 30, 2022 | 491,000.00 |
| Jun 30, 2022 | 811,000.00 |
| Mar 31, 2022 | 867,000.00 |
| Dec 31, 2021 | 698,000.00 |
| Sep 30, 2021 | 954,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 262,000.00 |